• Earth Science Tech has positioned itself as a diversified healthcare holding company focused on pharmaceutical compounding, telemedicine, healthcare services, and strict capital allocation.
• The company recently completed a vertically integrated telehealth and pharmacy ecosystem through the launch of MyOnlineConsultation.com, with telemedicine capabilities supporting patient acquisition, while pharmacy operations drive high-margin recurring prescription-based revenue streams.
• Above all, Earth Science Tech emphasizes balance-sheet strength and capital discipline through ongoing share repurchase initiatives designed to reduce dilution and support shareholder value.
• The growing company operates multiple subsidiaries spanning compounding pharmacies, telehealth platforms, clinics, healthcare support services, real estate and cash management.

Over the past several years, Earth Science Tech (OTC: ETST), a strategic holding company, has undergone a significant transformation. Divesting legacy wellness operations, the company has repositioned itself to acquire and scale cash-flowing assets across healthcare, pharmaceutical compounding and telemedicine, alongside active cash management, through a growing network of subsidiaries operating under the umbrella of a diversified holding company structure.

Today, the company executes a strategy focused on acquiring and actively managing businesses capable of generating sustainable long-term cash flow across regulated healthcare, real estate, cash management, and related industries. That transition became more visible in March when Earth Science Tech announced the formal launch of MyOnlineConsultation.com through MOCTeledoc LLC, a telehealth division designed to provide integrated physician networks, technology infrastructure and clinical staffing services (https://ibn.fm/cAxV7).

The launch marked the completion of what management calls a vertically integrated healthcare ecosystem linking telemedicine consultations directly with the company’s pharmacy operations.

According to the company, MOCTeledoc completed its beta phase as a cash-flow-positive operation, an outcome management cited as validation of the division’s lean, high margin operating structure. The telehealth platform now connects directly with Earth Science Tech’s wholly owned compounding pharmacy subsidiaries, including RxCompoundStore.com and Mister Meds, while also maintaining flexibility to route prescriptions to external pharmacy partners when appropriate.

By internalizing the patient journey from front-end consultation to back-end prescription fulfillment, Earth Science Tech captures margin across the entire care continuum. In this model, telemedicine services often function as a low-friction customer acquisition channel for patients seeking consultations, customized medications or ongoing healthcare management. Compounding pharmacies, meanwhile, can generate high-retention, repeat prescription activity over extended periods. By linking the two operationally, Earth Science Tech optimizes customer lifetime value (“LTV”), creating a healthcare ecosystem where patient engagement, prescription fulfilment and clinical support reinforce one another internally.

The company’s healthcare operations are now spread across multiple subsidiaries.

RxCompoundStore.com, a licensed compounding pharmacy based in Florida, and Mister Meds based in Texas, are authorized to fulfil prescriptions across more than 33 U.S. states and Puerto Rico, with additional licensing expansion underway. Additional healthcare exposure comes through Peaks Curative, DOConsultations, and Las Villas Health Care, which together support telemedicine consultations, customized medication delivery, and specialized healthcare services including outreach to Spanish-speaking patient communities.

Outside healthcare, Earth Science Tech mitigates risk and builds tangible equity through Avenvi, its dedicated property development and cash management division. Avenvi serves as a vital pillar in the company’s broader strategy to generate non-correlated revenue streams and build hard asset value. The division manages its physical property developments and its real estate assets currently include multiple lots, one developed residential property, and the one standalone commercial property. Highlighting the operational synergies within Earth Science Tech’s holding structure, this commercial building serves as the physical operating facility for the company’s Mister Meds pharmacy subsidiary. By combining disciplined cash management with tangible real estate assets, Avenvi balances the high-growth nature of the healthcare subsidiaries with stable, alternative asset classes, anchoring the balance sheet and ensuring the holding company is not solely reliant on the medical sector, providing a durable foundation for long-term equity growth.

That diversified structure reflects the company’s broader holding company approach, leveraging assets and cash flows from multiple sectors. Importantly, management has also actively distinguished the company through rigorous capital allocation and shareholder-focused initiatives. 

One area that has drawn attention among investors is Earth Science Tech’s ongoing share repurchase activity. Unlike micro-cap peers reliant on dilutive financing, ETST utilizes free cash flow to systematically execute buybacks. This continuously reduces the number of publicly traded shares outstanding, directly mitigating dilution while signaling management confidence in long-term operating performance and fundamental value. The company has indicated that share retirement initiatives are expected to continue as part of its broader capital management strategy.

For micro-and small-cap public companies, disciplined capital allocation carries particular significance. Investors often scrutinize dilution risk closely, especially among emerging growth businesses operating in capital-intensive sectors. Earth Science Tech’s emphasis on stock buybacks, tangible asset growth through Avenvi, and self-funded scaling directly addresses those concerns while reinforcing strict balance-sheet discipline.

The company has also worked to strengthen its regulatory positioning, operating under SIC 2834 pharmaceutical classification standards and has securing FINRA Form 211 clearance, measures that improve transparency and market credibility among institutional and retail investors evaluating OTC-listed healthcare companies. 

The macroeconomic market backdrop supports ETST’s continued growth opportunities across expanding total addressable markets (“TAM”). The pharmaceutical compounding industry has expanded steadily as demand rises for personalized medications, dosage customization and flexible supply alternatives. Industry research cited by the company estimates the global compounding pharmacy market was valued at approximately US$13.1 billion in 2023 and could reach US$18.6 billion by 2030.

Telemedicine growth has been even more pronounced. Forecasts referenced by the company project the global telemedicine market could expand from approximately US$112 billion in 2025 to more than US$530 billion by 2034 as digital healthcare adoption accelerates. North America remains the largest regional telemedicine market.

Earth Science Tech’s integrated operating model to position the company at the intersection of diverse secular economic trends: scalable digital healthcare delivery, high-margin pharmaceutical fulfilment, and tangible asset accumulation through real estate and disciplined cash management. The company’s combination of recurring pharmacy revenue, telemedicine infrastructure, Avenvi’s active cash management and property holdings, and shareholder-focused capital management, distinguishes it from speculative, cash-burning early-stage healthcare companies operating in fragmented digital health markets.

For more information, visit the company’s website at www.EarthScienceTech.com.

NOTE TO INVESTORS: The latest news and updates relating to ETST are available in the company’s newsroom at https://ibn.fm/ETST

Disseminated on behalf of Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) and may include paid advertising.

• Powermax Minerals is expanding its North American rare earth element exploration portfolio across Canada and the United States to address the significant dependence on China for processed rare earth materials supporting key defense and industrial applications.
• China controls roughly 60% of global rare earth mining and approximately 90% of downstream processing capacity.
• Growing Pentagon demand for drones, missile systems, and advanced electronics, continues to ratchet up demand for secure non-Chinese rare earth supply chains.
• Powermax recently moved to acquire the Hopkins Rare Earths Project in northern Ontario, adding to projects in British Columbia, Ontario, and Wyoming.
  

As the United States accelerates efforts to rebuild domestic supply chains for critical minerals, exploration companies focused on rare earth elements are attracting growing investor attention. Among them is Powermax Minerals (CSE: PMAX) (OTCQB: PWMXF), a Canadian mineral exploration company focused on rare earth projects across North America. The company is assembling a portfolio of important rare earth element (“REE”) projects in North America at a time when geopolitical concerns and defense requirements are reshaping how governments approach strategic mineral supply.

Rare earth elements are essential to a broad range of modern technologies, including electric vehicles, wind turbines, advanced electronics, military guidance systems, jet engines, and permanent magnets. The growing demand must be met with increased mining as well as economical processing and refining.

Industry estimates indicate China controls approximately 60% of global rare earth mining and roughly 90% of downstream processing capacity. Beijing has also imposed export restrictions and licensing requirements on several heavy rare earth elements and related technologies, raising concerns in Washington and among allied governments about long-term supply security.

The issue has become particularly urgent for the U.S. defense sector. A recent report highlighted that the Pentagon has ordered tens of thousands of one-way attack drones, with plans to scale production beyond 300,000 units by early 2028. Each drone depends on rare earth magnets, while roughly 98% of global magnet manufacturing remains centered in China (https://ibn.fm/vi2bb).

According to the same report, more than 80,000 components across approximately 1,900 U.S. weapons systems rely on Chinese rare earth materials or components. These include drone motors, missile guidance systems, sensors and aerospace applications.

The distinction between light and heavy rare earth elements is becoming increasingly important in strategic planning. Light rare earths such as neodymium and praseodymium are commonly used in permanent magnets for electric vehicles and electronics. Heavy rare earths including dysprosium and terbium play a critical role in maintaining magnet performance under high temperatures and harsh operating conditions typical of military systems and aerospace applications.

Western governments are now attempting to reduce that dependency. The U.S. Department of Defense and other federal agencies have directed substantial funding toward rare earth development through government instruments including the Defense Production Act. The Pentagon’s investment activity has included equity participation and financing commitments designed to support domestic and allied supply chains.

At the same time, industry analysts caution that developing alternative processing capacity is a long-term undertaking. Building mines may take several years, but establishing metallurgical expertise, refining capability and qualified downstream manufacturing systems can require considerably longer.

That broader backdrop has helped increase interest in companies such as Powermax Minerals as a potentially critical component in the supply chain. The company’s portfolio includes the Cameron REE property in British Columbia, the Atikokan and Pinard projects in Ontario, and the Ogden Bear Lodge Project in Wyoming. 

Recently, Powermax also announced an option agreement to acquire a 100% interest in the Hopkins Rare Earths Project in northern Ontario. The Hopkins property covers approximately 5,900 hectares within the Clay-Howells Alkalic Rock Complex, a geological setting associated with rare earth exploration activity. Planned exploration work includes airborne geophysics, radiometric surveys, geological mapping and geochemical sampling. Management says the acquisition is intended to strengthen the company’s growing North American REE portfolio and increase exposure to jurisdictions viewed as geopolitically stable.

These developments come as global demand for rare earth elements is projected to rise sharply over the coming decade, driven by electrification, renewable energy deployment, artificial intelligence infrastructure, robotics and military modernization. Industry forecasts cited by the company suggest global REE demand could triple from approximately 59,000 tonnes in 2022 to roughly 176,000 tonnes by 2035.

For more information, visit the company’s website at www.PowermaxMinerals.com.

NOTE TO INVESTORS: The latest news and updates relating to PWMXF are available in the company’s newsroom at https://ibn.fm/PWMXF

Exploration Target Cautionary Statement

The exploration targets discussed are conceptual, and there is currently not enough data to confirm a mineral resource. Further exploration may not yield successful results.

Disseminated on behalf of ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) and may include paid advertising.

• ESGold Corp., a development-stage company committed to the acquisition, exploration, and development of high-quality mineral properties worldwide, is optimistic about historically high gold prices
• With the ongoing global political issues, there has been oil-driven inflation and a general lack of faith in traditional stores of wealth, which experts note are long-term drivers of gold prices
• ESGold has positioned itself to take advantage of this growth, being fully funded to execute, and is on track to kicking off production at its flagship Montauban Gold-Silver Project in Quebec
• Gordon Robb, ESGold’s CEO, has noted that 2026 will be a major year for the company, with important milestones being achieved, and with ongoing market factors in their favor

ESGold (CSE: ESAU) (OTCQB: ESAUF), a development-stage company committed to acquiring, exploring, and developing high-quality mineral properties worldwide, remains optimistic about gold prices in 2026 and is positioning itself to take advantage of it. This comes amid growing oil-driven inflation and debt factors which continues to highlight gold as a safety hedge, both for the short-term and long-term (https://ibn.fm/BGLjF).

As of May 21, 2026, the price of gold was trading at $4,504 an ounce, up from $3,312 a year ago. According to JPMorgan, it is projected that by year-end, this price will likely hit close to $6,000 per troy ounce, a key signal pointing to the potential gold has for growth and its viability as an important hedge investment vehicle (https://ibn.fm/waijw).

The ongoing global issue as well as the high price of crude oil are key to shaping this outcome as time progresses. Higher oil prices have increased inflation risks, all while increasing chances of higher-for-longer interest rates. Regardless, ESGold believes there is still value in gold as a hedge against this inflation and looks to capitalize on its anticipated uptake.

“Given the current high negative correlation to oil, dollar, and yields, these – especially oil – will set the tone for gold in the upcoming sessions,” noted Ole Hansen, head of commodity strategy at Saxo Bank (https://ibn.fm/BGLjF).

Back in the 1970s, high inflation, paired with weak economic growth, led to massive gains in gold. Between 1976 and 1080, the price of a troy ounce grew from $125 to $859. The pattern was further replicated in the 2020s, when there was a global inflationary spike, with gold serving as a crucial defensive asset, which led to its price rising. Experts point out that the pattern might repeat itself this year as well, with the ongoing global political climate and the oil-induced inflation. As a result, ESGold is positioning itself to capitalize on the spike in demand and the accompanying surge in gold prices.

Thus far, the company has positioned itself for growth and set itself up for success. It is fully funded to execute and is on track to kick off production at its flagship Montauban Gold-Silver Project in Quebec. Earlier this month, it expanded its Montauban footprint with a 2,448-hectare strategic claim and bolstered its senior leadership, with Jason Tong as its new Chief Financial Officer (“CFO”). Gordon Robb, the company’s CEO, has reiterated that 2026 will be a big year 2026 will be for ESGold, and the steps taken so far, the milestones achieved, and the current state of the world, it is safe to say that the company is on track to have its best year yet.

For company information, visit the company’s website at www.ESGold.com.

NOTE TO INVESTORS: The latest news and updates relating to ESAUF are available in the company’s newsroom at https://ibn.fm/ESAUF

• GelrinC(R) is positioned as a potential first-in-class, off-the-shelf solution for knee cartilage repair in the U.S., offering a single-step procedure that simplifies treatment and integrates into standard surgical workflows.
• Clinical data show ~100% greater pain improvement versus microfracture, with durable outcomes and MRI-confirmed regeneration of near-native cartilage.
• A single ~10-minute procedure with ~2-week recovery and lower costs versus cell-based therapies supports strong adoption across surgeons, payers, and patients.
• The product targets an estimated ~$3 billion U.S. market with ~470,000 annual cases and no comparable ready-to-use competitor.
• Advancing through a pivotal Phase III trial with CE Mark approval in Europe, the company is approaching key catalysts including commercialization and FDA submission.

Regentis Biomaterials (NYSE American: RGNT) is taking aim at a $3 billion U.S. market with what could be the first true off-the-shelf solution for knee cartilage repair—no cells, no delays, no complexity. Its GelrinC(R) platform delivers faster recovery, stronger outcomes, and lower costs vs. outdated procedures, with clinical data showing ~100% greater pain improvement vs. microfracture. Already CE Mark approved in Europe and advancing through a pivotal U.S. Phase III trial, Regentis is stacked with near-term catalysts that could redefine orthopedic care—and unlock massive upside.

Company Overview

Regentis is a regenerative medicine company dedicated to developing innovative tissue repair solutions that restore health and enhance quality of life. With an initial focus on knee injuries and other orthopedic treatments, Regentis’ Gelrin(TM) platform technology, based on synchronized, degradable hydrogel implants, regenerates damaged or diseased tissue including inflamed cartilage and bone. Regentis’ lead product GelrinC(R) is a cell-free, off-the-shelf hydrogel that is eroded and resorbed in the knee, allowing the surrounding cells to regenerate durable and healthy cartilage in a controlled and synchronous process with sustained results. GelrinC(R) aims to address an estimated $3 billion annual U.S. market of approximately 470,000 cases of knee cartilage repair, where no off-the-shelf treatment is available. It has CE Mark approval for commercialization in Europe and has completed more than 50% enrollment in its pivotal Phase III study for U.S. FDA approval. Several upcoming value-driving catalysts include completion of the U.S. pivotal trial, commercialization in Europe, and submission for FDA approval in the U.S.

Investment Highlights

Positioned as a First-in-Class Off-the-Shelf Solution for Knee Cartilage Repair in the U.S.

GelrinC(R) is built to disrupt a broken standard of care. A true single-step, off-the-shelf implant, it eliminates cell harvesting, lab delays, and multi-stage surgeries. While legacy treatments are either ineffective or overly complex, GelrinC(R) delivers a fast, ~10-minute procedure that fits seamlessly into existing workflows. This is a category-defining product with the potential to displace both microfracture and expensive cell-based therapies.

Compelling Clinical Efficacy That Outperforms Legacy Treatments

GelrinC(R) isn’t just simpler—it’s clinically superior. Data shows ~100% greater improvement in pain scores vs. microfracture at two years, with durable, multi-year outcomes and no adverse events to date. MRI results confirm near-complete cartilage regeneration, the gold standard in the field. This is the rare combination investors look for: clear, measurable superiority with lasting results.

Stronger Economics That Accelerate Adoption

GelrinC(R) aligns with how healthcare actually works: faster, cheaper, and easier. A single minimally invasive procedure, ~2-week recovery (vs. ~6 weeks), and significantly lower costs than $40K+ cell therapies create a powerful value proposition. The result: high-margin scalability with strong incentives for surgeons, payers, and patients alike.

Large, Underpenetrated Market with Clear Catalysts Ahead

Targeting a ~$3B U.S. market with ~470K annual cases, GelrinC(R) is entering a space with massive unmet demand and no true off-the-shelf competitor. With CE Mark approval already secured in Europe and a U.S. pivotal trial over 50% enrolled, Regentis is approaching major value inflection points—including trial completion, FDA submission, and commercialization. This is a high-upside, catalyst-rich story investors can’t ignore.

Leadership Team

Ehud Geller, PhD, MBA, Chief Executive Officer and Executive Chairman, brings extensive leadership experience in the pharmaceutical and biotechnology industries, having previously served as President and CEO of Interpharm Laboratories and as an executive vice president at Teva Group, along with leadership roles in industry organizations and public markets.

Galit Reske, PhD, Chief Medical Officer, has significant expertise in clinical development and regulatory strategy, including leading roles in global clinical operations and contributing to the FDA approval of the cartilage repair product Agili-C, which was later acquired by Smith+Nephew in a $330 million transaction.

Ori Gon, CPA, Chief Financial Officer and Chief Business Officer, has more than 15 years of financial leadership experience across public and private companies and has led multiple capital raises totaling over $150 million.

Nadya Lisovoder, MD, Director of Clinical Operations, has broad experience managing clinical studies across multiple geographies and therapeutic areas, overseeing programs from early-stage development through regulatory submission in the United States, Europe, Israel, and Australia.

For more information, visit the company’s website at https://www.regentis.co.il.

NOTE TO INVESTORS: The latest news and updates relating to RGNT are available in the company’s newsroom at https://ibn.fm/RGNT

Two of the Web3 community’s most recognized programming tracks rejoin Canada’s flagship event, bringing dedicated developer and women-focused experiences to Rebel Entertainment Complex this July

Blockchain Futurist Conference is pleased to confirm that both ETHWomen and ETHToronto will once again be featured as part of the 2026 Toronto programme, taking place July 21–22 at Rebel Entertainment Complex and Cabana Pool Bar.

Now in its fifth annual edition, ETHToronto returns on July 22 as the Web3 developer experience at Blockchain Futurist Conference. Organized by the team behind some of Canada’s longest-running crypto events since 2013, ETHToronto brings together builders, hackers, developers, and innovators from across Ethereum and the broader Web3 ecosystem. ETHToronto 2026 is proudly sponsored byAutheo. The event is free to register and open to all conference attendees, running as a dedicated programming track within the Futurist venue. Registration is available at www.ethtoronto.ca.

ETHWomen returns across both conference days, July 21–22, as a dynamic and community-driven experience dedicated to connecting, celebrating, and advancing women in the Web3 and blockchain space. Now an established fixture within Blockchain Futurist Conference, ETHWomen has grown into a global initiative that convenes hundreds of women through sessions focused on networking, collaboration, and learning. This year’s programming will also feature a breakfast sponsored by SheFi and a facilitated networking session sponsored by Women in Crypto. Free passes are available and tickets are limited, so those interested are encouraged to register early at www.ethwomen.com.

Confirmed ETHWomen 2026 speakers include Staci Warden, CEO of the Algorand Foundation; Ada Vaughan, Senior Director of DeFi Partnerships at the Stellar Development Foundation; Janet Adams, Board Member of the Artificial Superintelligence Alliance and COO of SingularityNet; Jaime Leverton, CEO of ReserveOne; and Lisa Loud, Executive Director of Secret Network. Additional speakers will be announced in the weeks ahead.

Both ETHWomen and ETHToronto are included with the purchase of a General Pass to Blockchain Futurist Conference Toronto 2026, reinforcing the conference’s commitment to providing a multi-layered, high-value experience across the full two days. Together with the AI Futurist Conference, Beginner Bootcamps, and the broader Canada Crypto Week side event programming, they reflect Futurist’s ongoing investment in building an event ecosystem rather than a single-day show.

ETHWomen will also make its return in the United States alongside the Florida edition of Blockchain Futurist Conference, with dates set for November 17–18, 2026.

Conference Tickets (includes ETHWomen & ETHToronto): futuristconference.com/toronto/ticket

ETHWomen Sponsorships: ethwomen.com/sponsorship-form

ETHToronto Registration (Free): www.ethtoronto.ca

ETHWomen Registration (Free): www.ethwomen.com

For media passes or media inquiries, please contact james@futuristconference.com

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising.

• AI-powered security and defense solutions company Safe Pro Group recently released its financial results for the quarter ending March 31, 2026, showing a 560% quarterly revenue increase, driven by 2,400% growth in its high margin AI revenue, and a strong balance sheet.
• In addition to finances, Safe Pro also revealed some operational highlights, such as delivering Edge processing systems to the U.S. Government, offering support for Edge processing, an expanded leadership team, and a growing interest in its solutions.
• Safe Pro also launched a new growth team, led by Brian Mack as Chief Growth Officer and Benjamin Chitty, VP of Government Growth, which will lead its efforts to capture U.S. government contract awards through teaming agreements with Prime Contractors.

Safe Pro Group (NASDAQ: SPAI), a tech company that delivers AI-powered security and defense solutions, recently revealed its financial results for the quarter ending March 31, 2026 (https://ibn.fm/RLuo5). The highlights showed significant growth driven by the sales of its AI products.

Safe Pro Group’s quarterly revenue rose to over $1,220,129, up from the $184,8092 reported in the first quarter of 2025. This represents a 560% increase. Safe Pro AI quarterly revenue jumped over 2,400%, largely driven by new contracted sales of its AI-powered and drone-based video and image analysis systems.

Safe Pro’s quarterly consolidated gross margins were more than 68% inclusive of deprecation, validating its scalable business model. At the end of the quarter, Safe Pro supported a strong balance sheet with $14.8 million in cash and only minimal debt.

The company also covered important operational results from the quarter.

This includes Safe Pro delivering multiple Edge processing systems under a $1,000,000 government contract, as well as a contract modification that expanded this to also include providing support for these Edge processing systems.

The interest in Safe Pro’s Navigation, Observation & Detection Engine (“NODE”), and the new NODE-X miniaturized Edge processing solution, continues to grow following several live demonstrations and exercises conducted by the U.S. Army. By participating in these events, Safe Pro has the opportunity to directly engage with decision-makers in the defense industry who may be able to offer a path to product acquisition and deployment.

The company has also expanded its leadership team, and launched a new Growth Team (https://ibn.fm/AQtOI). The team is led by Brian Mack as the Chief Growth Officer and Benjamin Chitty as the VP of Government Growth. This group is leading Safe Pro’s efforts to get more U.S. government awards via teaming agreements with Prime Contractors.

Speaking about these results and the future of Safe Pro, the Chairman and CEO of Safe Pro Group, Dan Erdberg, said that “We believe Safe Pro is well positioned to capitalize on the AI era with the momentum we see building for our patented AI solutions within the U.S. Government. Supported by a strong balance sheet, expanded team of accomplished military acquisition specialists, and an enhanced portfolio of real-world proven solutions, we are excited about our future.”

About Safe Pro Group Inc.

Safe Pro Group is a mission-driven tech company that delivers advanced and AI-powered security and defense solutions to industries like law enforcement, humanitarian, homeland security, and defense. It offers drone-based services and ballistic protective gear, and the core of Safe Pro’s offering is its patented computer vision software technology that can rapidly detect small objects in drone-based videos and images, to enable more efficient and safe field operations.

For more information, visit Safe Pro Group’s website at www.SafeProGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to SPAIF are available in the company’s newsroom at https://ibn.fm/SPAIF

Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) and may include paid advertising.

• Near-term gold producer LaFleur Minerals is reporting new assay results from infill diamond core drilling that bolster expectations that mineralization remains open at depth and along strike in the company’s Swanson Gold Deposit
• The findings follow up on the mineral resource estimate completed earlier this year with the potential for additional high-grade shoots within the system and broader zones of gold mineralization
• LaFleur’s nearly 22,400-hectare Swanson and McKenzie East gold projects are located within the prolific Abitibi Greenstone Belt of eastern Canada, within the Val-d’Or mining camp where labor and supply resources are centralized for mining operations in the region

Infill diamond-core drilling continues to yield a path to the potential expansion of resources in the Abitibi Greenstone Belt-situated Swanson Gold Deposit owned and operated by near-term gold producer LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF).

The company’s flagship property in Eastern Canada’s prolific gold mining district — one of the largest gold belts in the world — combined with the recently acquired McKenzie East Gold Project nearby, covers more than 450 exploration mining claims that are located on nearly 22,400 hectares (about 55,350 acres).

LaFleur’s May 12 news release provides an outline of significant assay results from the company’s ongoing drilling program at its Swanson Gold Deposit, highlighting findings of 2.95 g/t Au over 80.00 meters, 2.37 g/t Au over 88.05 meters, 1.29 g/t Au over 93.85 meters, and 0.86 g/t Au over 103.55 meters plus 1.14 g/t Au over 56.65 meters in four of the seven newly reported drill holes (https://ibn.fm/FcTIO).

The assays have increased confidence that continuity of mineralization exists both within and beyond LaFleur’s proposed pit shell at depth, enhancing the mineral resource estimate completed just a few months ago with the potential for high-grade shoots within the system at depth.

The drill program focused on previously untested depths where spacing between historical drill holes exceeded 50 meters, establishing higher grade sub-intervals, such as 232.00 g/t Au over 0.50 meters, 3.98 g/t Au over 9.00 meters and 7.78 g/t Au over 1.90 meters between two of the holes and leaving mineralization open at depth and along strike.

Visible gold was encountered in three of the seven recently drilled holes. 

“LaFleur has intersected some of the strongest and widest gold mineralization to date at its Swanson Gold Project, indicating the presence of broad zones of gold mineralization extending beyond the limits of the current open pit resource at the Swanson Gold Deposit and highlighting the emergence of a potentially much larger, high-growth gold system with compelling expansion potential,” LaFleur Chairman Kal Malhi stated.

Swanson is located in the Val-d’Or mining district — an established central hub for labor and other resources that support mineral exploration activities in the Abitibi. The company completed a Preliminary Economic Assessment (“PEA”) in March that anticipates a strong economic return from the project and the company’s nearby Beacon Gold Mill, which is expected to resume gold production operations during the next quarter.

LaFleur is building its profitability forecast on a base case price closer to where gold traded in January 2025 instead of current levels, meaning that the metal’s price remains far above the level LaFleur sees as the foundation for its strategy. The gold market has since achieved historic highs as it more than doubled value after January 2025, and the precious metal continues to trade at lofty levels despite recent price fluctuations that have sometimes challenged the expectations of investors (https://ibn.fm/luwBz).

For more information, visit the company’s website at LaFleurMinerals.com.

NOTE TO INVESTORS: The latest news and updates relating to LFLRF are available in the company’s newsroom at https://ibn.fm/LFLRF

Qualified Person Statement:

All scientific and technical information contained in this article has been reviewed and approved by Louis Martin, P.Geo. (OGQ), Exploration Manager and Technical Advisor of the company and considered a Qualified Person for the purposes of NI 43-101.

• OTLC completed a $12.5M monetization of its N2B CNS delivery system with Lunai Bioworks, targeting Alzheimer’s and biodefense applications
• The deal grants field-specific IP rights while preserving Oncotelic’s development in other CNS indications
• The move aligns with the rising industry focus on blood-brain barrier (“BBB”) bypass technologies and platform-based CNS drug delivery

Oncotelic Therapeutics (OTCQB: OTLC) is advancing its position in one of biotechnology’s most persistent and commercially significant challenges: drug delivery to the central nervous system (“CNS”). As the industry increasingly recognizes the blood-brain barrier (“BBB”) as a primary constraint in neurological drug development, companies developing delivery-focused platforms are gaining increased attention across both biodefense and healthcare markets (ibn.fm/zuYfT).

According to a recent BioMedWire editorial, “CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities,” this shift is highlighted, noting that the BBB prevents the majority of therapeutics from reaching the brain and contributes to higher failure rates in CNS drug pipelines. With the increase in Alzheimer’s disease cases globally and biodefense preparedness becoming a growing priority, the article underscores that innovation is focused on bypassing biological barriers rather than solely on developing new drug compounds.

In this context, Oncotelic Therapeutics is advancing its proprietary intranasal nose-to-brain (“N2B”) delivery system, created to bypass the BBB and enable direct therapeutic access to the CNS. The platform highlights a wider industry transition toward scalable, platform-based delivery technologies capable of addressing multiple high-value indications, including neurodegenerative disease and emergency medical countermeasures.

The company recently announced the closing of an important monetization agreement with Lunai Bioworks, Inc., involving its N2B delivery system. In this agreement, Oncotelic granted worldwide rights to the N2B intellectual property within defined fields of Alzheimer’s disease and biodefense medical countermeasures. In return, the company recently received $12.5 million in Series B convertible preferred stock. Oncotelic retains development rights in additional CNS indications, including Parkinson’s disease and other therapeutic areas.

The transaction highlights a dual-track strategy: near-term value realization through targeted IP monetization, alongside long-term optionality across broader CNS applications. Management noted that the company continues to evaluate additional partnerships to monetize its portfolio further while maintaining strategic control over its core assets.

The N2B system itself represents a device-enabled intranasal delivery approach created to transport therapeutic agents directly into CNS pathways, bypassing systemic circulation constraints. This mechanism is especially relevant in both chronic neurodegenerative diseases and acute biodefense scenarios, where rapid brain delivery and targeted neurological action are vital (ibn.fm/nG4eS).

The Alzheimer’s disease market ranks as one of the biggest unmet needs in the global healthcare ecosystem, with millions of patients worldwide and continued growth expected as populations grow older. Despite significant research investment, many therapies fail in clinical development due to insufficient brain penetration, underscoring the importance of improved delivery mechanisms.

Beyond commercial healthcare, CNS delivery technologies are also gaining relevance in biodefense and national security applications. Government agencies, including BARDA and the U.S. Department of Defense, continue to prioritize medical countermeasures capable of rapid CNS intervention in response to chemical and biological threats.

As the biotechnology sector increasingly shifts toward platform-based innovation, delivery technologies such as N2B are becoming central to long-term value creation. Oncotelic Therapeutics’ continued advancement and monetization of its CNS delivery platform positions the company within this emerging segment, where solving the delivery bottleneck may prove as important as drug discovery itself.

Public-market examples such as Sangamo Therapeutics, Inc. (SGMO), CytoDyn Inc. (CYDY), Netlist, Inc. (NLST), and NorthWest Biotherapeutics, Inc. (NWBO) demonstrate continued investor appetite for platform-driven companies built around proprietary technology ecosystems, infrastructure-layer intellectual property, and long-duration scientific optionality beyond any single product candidate.

For more information, visit the company’s website at www.Oncotelic.com.

NOTE TO INVESTORS: The latest news and updates relating to OTLC are available in the company’s newsroom at ibn.fm/OTLC

Disseminated on behalf of Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) and may include paid advertising.

• The importance of space exploration and commercialization has grown dramatically in recent years.
• Planet Ventures’ recent investment in Lux Aeterna reflects a strategic effort to gain exposure to technologies tied to the next phase of the commercial space industry.
• Lux Aeterna is a space infrastructure company building the industry’s first fully reusable satellite platform.

Space exploration is increasingly viewed not only as a scientific endeavor but also as a major economic and technological frontier capable of reshaping communications, energy systems, manufacturing and national security. Governments and private companies are investing billions into technologies that could support a long-term space economy, creating opportunities for investors seeking exposure to emerging infrastructure and advanced aerospace systems. Planet Ventures (CSE: PXI) (OTC: PNXPF) is positioning itself within that evolving landscape through a new investment in Lux Aeterna, a space infrastructure company building the industry’s first fully reusable satellite platform.

The importance of space exploration and commercialization has grown dramatically in recent years. According to the World Economic Forum and McKinsey & Company, the global space economy could reach approximately $1.8 trillion by 2035 as space-enabled technologies become increasingly integrated into communications, navigation, energy, logistics and defense systems. The report highlights how space is evolving from a niche sector into a foundational layer of global infrastructure.

Much of the early commercial space industry focused primarily on launch providers and satellite deployment. However, the market is now shifting toward technologies that support long-term operations in orbit, including robotic systems, in-space servicing, autonomous spacecraft and orbital infrastructure. Agencies such as NASA have repeatedly emphasized that sustainable space operations will require advanced technologies capable of supporting persistent activity in orbit and beyond.

This broader evolution is helping drive interest in companies developing infrastructure-oriented solutions rather than simply launch systems. The ability to service spacecraft, extend mission life, improve orbital efficiency and reduce operational costs is becoming increasingly important as more governments and businesses rely on satellites and space-based systems.

Planet Ventures’ recent investment in Lux Aeterna reflects a strategic effort to gain exposure to technologies tied to the next phase of the commercial space industry. Planet Ventures announced an investment in Lux Aeterna, stating that the company is leading a structural shift in the global space economy, which has spent decades optimizing around a disposable satellite model.

The announcement notes that Lux Aeterna’s reusable fleet of satellites is designed to close the loop on the orbital supply chain and create a persistent logistics layer between Earth and orbit. This concept is significant because most satellites today are either stranded in orbit due to a system failure, retired to a graveyard orbit, or burned up on reentry. Technologies that allow servicing, refueling or redeployment of satellites could substantially improve the efficiency and economics of orbital infrastructure.

Planet Ventures’ investment aligns with the company’s broader strategy of identifying emerging technologies capable of benefiting from long-term industry transformation. The company is focused on sectors including artificial intelligence, robotics, space technology and next-generation infrastructure systems.

The strategic importance of reusable and serviceable spacecraft technologies is also gaining recognition across the broader industry. The European Space Agency has highlighted in-orbit servicing and satellite sustainability as critical priorities for the future of commercial and governmental space operations. As the number of satellites in orbit increases, the ability to maintain and extend the usefulness of these assets may become essential to managing congestion, reducing debris and improving operational resilience.

Planet Ventures’ investment represents more than a simple portfolio addition. It reflects participation in a larger shift occurring within the commercial space sector, where value creation is increasingly moving toward enabling technologies and infrastructure solutions. Rather than focusing solely on launch providers, investors are beginning to look at companies building the systems that can support long-duration and scalable economic activity in space.

The investment may also strengthen Planet Ventures’ broader positioning within the space technology ecosystem. The company has previously highlighted exposure to orbital energy systems and space robotics through investments connected to Mantis Space and General Astronautics. Adding Lux Aeterna expands that thematic approach by introducing exposure to satellite sustainability and servicing technologies, areas expected to become increasingly important as orbital infrastructure grows more complex.

As commercial space activity continues expanding, infrastructure-oriented technologies may become some of the most strategically valuable components of the sector. Satellites, communications networks and orbital systems will require maintenance, servicing and operational support if the broader space economy is to mature sustainably. Companies developing those capabilities could therefore occupy an increasingly important role in the sector.

For Planet Ventures, the Lux Aeterna investment appears aligned with a long-term view that the next stage of space commercialization will be defined not only by reaching orbit but by building the infrastructure needed to operate there efficiently. By investing in reusable and serviceable spacecraft technologies, the company is positioning itself around what many industry observers believe could become one of the most important trends in the evolving space economy.

For more information, visit www.PlanetVenturesInc.com.

NOTE TO INVESTORS: The latest news and updates relating to PNXPF are available in the company’s newsroom at https://ibn.fm/PNXPF

Disclaimer

Investor Brand Network (“We” or “Us”) are not securities dealers or brokers, investment advisers or financial advisers, and you should not rely on the information herein as investment advice. Planet Ventures Inc. will make aggregate payments of $100,000  to us to provide marketing services for a term of 1 year. This article is informational only and is solely for use by prospective investors in determining whether to seek additional information. This does not constitute an offer to sell or a solicitation of an offer to buy any securities. Our stock profiles are intended to highlight certain companies for your further investigation; they are not stock recommendations or constitute an offer or sale of the referenced securities. The securities issued by the companies we profile should be considered high risk; if you do invest despite these warnings, you may lose your entire investment. Please do your own research before investing, including reading the companies’ SEDAR+ and SEC filings, press releases, and risk disclosures.

Forward-Looking Statements

This document contains forward-looking statements within the meaning of applicable securities legislation. Such statements include, without limitation, statements regarding: Planet Ventures’ investment strategy and objectives; anticipated developments in the commercial space industry, including the growth of orbital energy and space robotics markets; the projected growth of the global space economy; Planet Ventures’ expectations regarding the strategic importance of its investments in Mantis Space and General Astronautics; the anticipated role of orbital energy technologies and robotic servicing systems in future in-orbit operations; and the potential for these technologies to become foundational to the next generation of commercial space activity.

Forward-looking statements are not guarantees of future performance. Readers are cautioned not to place undue reliance on forward-looking statements. The forward-looking statements contained in this document are made as of the date hereof and Planet Ventures undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by applicable securities laws.

Risk Factors

Investing in Planet Ventures and its portfolio companies involves a high degree of risk. The following is a summary of key risk factors. This is not an exhaustive list, and additional risks may exist that are not currently known:

• Early-Stage Investment Risk. Portfolio companies have limited operating histories and are pre-revenue. Investments are speculative and may result in a total loss of capital.
• Technology Risk. The orbital energy and lunar habitation technologies underlying the company’s investments are unproven at commercial scale and may not be successfully developed or deployed.
• Regulatory Risk. Space sector operations require licenses and approvals from domestic and international regulatory bodies. Failure to obtain or maintain these could materially delay or prevent operations.
• Market Risk. Commercial demand for in-space power systems and lunar services has not been established at scale. Projected market growth may not be realized within anticipated timeframes.
• Liquidity Risk. Investments in private, early-stage companies are illiquid. There is no guarantee of a market for these securities or the ability to exit on favorable terms.
• Capital Risk. Portfolio companies may require additional funding that may not be available, or may be available only on dilutive or restrictive terms.
• Macroeconomic and Geopolitical Risk. Adverse macroeconomic conditions or geopolitical developments could disrupt the company’s investment strategy or the operations of portfolio companies.
• Key Personnel Risk. The company’s performance depends in part on retaining key personnel and advisors. Loss of key individuals could adversely affect the company’s operations and investment activities.

• The Jameson Land Basin in Greenland is emerging as one of the world’s largest remaining underexplored onshore hydrocarbon regions, spanning more than 8,400 square kilometers.
• By agreeing to fully fund the drilling at the project, Greenland Energy Company will acquire 70% of the project, while the remaining 30% remains with 80 Mile, the current owner of the project.
• Greenland Energy Company has contracted Halliburton, one of the largest companies in the space, to handle project management and offer support for logistics planning.

There are few opportunities in the global oil and gas sector as compelling as the Jameson Land Basin in Greenland, widely viewed as one of the world’s largest remaining underexplored onshore basins. Spanning more than 8,400 square kilometers (roughly 2 million acres), the basin has been the subject of extensive geological and seismic analysis over several decades, with historical industry estimates suggesting the broader basin system could contain tens of billions of barrels of oil equivalent.

The basin has attracted significant industry attention for decades, with historic exploration and related activity by major energy players representing more than $275 million in today’s dollar, including ARCO. That level of interest reflects the extraordinary scale and potential of the asset.

The asset is currently 100%-owned by 80 Mile, an exploration and development company that recently entered into an agreement with Greenland Energy (NASDAQ: GLND) to advance the project toward drilling.

Under the agreement, two 3,500-meter wells are scheduled to be drilled during the second half of 2026, with all drilling costs to be fully funded by Greenland Energy Company. Upon completion of the program, Greenland Energy Company will earn a 70% interest in the project, while 80 Mile will retain a significant 30% stake.

To support the initiative, Greenland Energy Company has partnered with Halliburton, one of the world’s largest oilfield services providers. The agreement covers integrated consulting services and logistical management, including the coordination, planning, transportation, and handling of equipment, services, and materials required for Arctic operations.

The collaboration with Halliburton, alongside additional agreements with Stampede Drilling, is expected to provide best-in-class drilling capabilities, operational expertise, and advanced technologies for what could become the first onshore exploration well ever drilled in the Jameson Land Basin.

Commenting on the Halliburton agreement, Greenland Energy Company CEO Robert Price stated: “By working with Halliburton, we can tap into world-class expertise and advanced technologies that will enhance drilling accuracy, safety, and efficiency under Arctic conditions. This agreement strengthens our operational platform and emphasizes our commitment to technical excellence and responsible development in a frontier basin.”

For more information, visit the company’s website at www.GreenlandEnergyCo.com.

NOTE TO INVESTORS: The latest news and updates relating to GLND are available in the company’s newsroom at https://ibn.fm/GLND

Forward-Looking Statements

This communication contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995 and within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended. All statements contained herein other than statements of present or historical fact, including, without limitation, statements regarding Greenland Energy Company’s (the “Company”) future financial performance, business strategy, operations, financial position, estimated revenues and losses, projected costs, prospects, plans, objectives of management, and expected benefits of the Company’s recent business combination, are forward-looking statements. Forward-looking statements are generally identified by the use of words such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “should,” “would,” “plan,” “project,” “forecast,” “potential,” “predict,” or the negative of these terms or similar expressions, although not all forward-looking statements contain such identifying words.

These forward-looking statements are based on management’s current expectations, assumptions and beliefs regarding future events and are based on information currently available to the Company. These statements involve a number of risks and uncertainties, many of which are difficult to predict and are beyond the Company’s control, and actual results may differ materially from those expressed or implied by these forward-looking statements. Factors that could cause actual results to differ materially include, among others: (i) Exploration and Geological Risks, including the Company’s status as a development-stage company with no operating history, revenues, or proved reserves; the inherent uncertainty in prospective resource estimates, including that the 13 billion barrel estimate is based on undiscovered accumulations with no certainty of discovery or commercial viability; geological complexity arising from limited seismic data coverage, pervasive igneous intrusions, faulting patterns, and significant Tertiary uplift creating thermal maturity uncertainty; the fact that the basin has never produced a commercial discovery despite decades of study dating back to the 1970s, and a 2008 USGS report stating less than a 10% chance of containing a technically recoverable hydrocarbon accumulation; and high-cost frontier exploration with estimated well costs of $40 million for the first well and $20 million for subsequent wells; (ii) Operational and Environmental Risks, including the challenges of operating in a remote Arctic location with extreme climate, harsh weather, limited daylight, no existing infrastructure, and seasonal access windows for equipment and personnel; drilling hazards such as blowouts, equipment failures, well control events, environmental releases, and accidents inherent in oil and gas operations; reliance on third-party contractors; and climate change scrutiny, as operations in Greenland face increasing opposition from environmental groups and institutional investors due to Arctic drilling concerns; (iii) Regulatory and Political Risks, including the 2021 Greenland drilling moratorium, and while licenses are grandfathered, future regulatory changes could jeopardize operations; geopolitical tensions, including U.S. interest in acquiring Greenland and Greenland’s internal independence movements that could affect operations; permit requirements, as drilling requires Environmental Impact Assessment approval and Field Activities Application approval from Greenlandic authorities; and forfeiture risk, as failure to meet drilling milestones could result in loss of the Company’s right to earn working interests; (iv) Financial and Capital Risks, including significant capital requirements and the need for substantial funding beyond current resources to complete the drilling program; commodity price volatility, as oil, gas, and NGL prices are highly volatile and will heavily influence project viability; a long development timeline during which market conditions may change significantly before potential production, unlike short-cycle shale projects; going concern uncertainty and substantial doubt about the Company’s ability to continue as a going concern without additional financing; and energy transition risk, as global demand for oil may decline due to electric vehicle adoption, renewable energy policies, and changing consumer preferences; and other risks and uncertainties as set forth in the Company’s Prospectus filed with the Securities and Exchange Commission pursuant to Rule 424(b)(4) under the Securities Act on April 29, 2026, in the section titled “Risk Factors.”

Forward-looking statements speak only as of the date they are made. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.